drugset / Trial / NCT00619710

Complicated Skin and Skin Structure Infections

NCT00619710

Phase 3 Completed 1000 enrolled Pfizer
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to demonstrate the non-inferiority of meropenem (Merrem) and imipenem in hospitalised subjects with complicated skin and skin structure infections.

Timeline

Start
2001-02
Primary completion
2003-12
Completion
2004-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Imipenem-Cilastatin Unknown Intravenous
Subject Meropenem Small molecule Intravenous